166 related articles for article (PubMed ID: 33284239)
1. Impact of p53, HIF1a, Ki-67, CA-9, and GLUT1 Expression on Treatment Outcomes in Locally Advanced Cervical Cancer Patients Treated With Definitive Chemoradiation Therapy.
Gaber G; El Achy S; Khedr GA; Parimi V; Helenowksi I; Donnelly ED; Strauss JB; Woloschak G; Wei JJ; Small W; Refaat T
Am J Clin Oncol; 2021 Feb; 44(2):58-67. PubMed ID: 33284239
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Nuclear Factor Kappa B Expression in Locally Advanced Cervical Cancer Patients Treated Definitively With Concurrent Chemoradiation.
Altoos B; Small C; Dalal P; Attieh D; El Achy S; Parimi V; Wei JJ; Helenowski I; Donnelly ED; Strauss J; Small W; Refaat T
Am J Clin Oncol; 2020 Jan; 43(1):47-51. PubMed ID: 31693509
[TBL] [Abstract][Full Text] [Related]
3. c-Met Overexpression in Cervical Cancer, a Prognostic Factor and a Potential Molecular Therapeutic Target.
Refaat T; Donnelly ED; Sachdev S; Parimi V; El Achy S; Dalal P; Farouk M; Berg N; Helenowski I; Gross JP; Lurain J; Strauss JB; Woloschak G; Wei JJ; Small W
Am J Clin Oncol; 2017 Dec; 40(6):590-597. PubMed ID: 26083558
[TBL] [Abstract][Full Text] [Related]
4. PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: A study based on immunohistochemistry and RNA sequencing data.
Koh YW; Lee SJ; Han JH; Haam S; Jung J; Lee HW
Lung Cancer; 2019 Mar; 129():41-47. PubMed ID: 30797490
[TBL] [Abstract][Full Text] [Related]
5. Microvascularization of Grade I meningiomas: effect on tumor volume, blood loss, and patient outcome.
Karsy M; Burnett B; Di Ieva A; Cusimano MD; Jensen RL
J Neurosurg; 2018 Mar; 128(3):657-666. PubMed ID: 28362240
[TBL] [Abstract][Full Text] [Related]
6. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
[TBL] [Abstract][Full Text] [Related]
7. The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy.
Li X; Wei LC; Zhang Y; Zhao LN; Li WW; Ping LJ; Dang YZ; Hu J; Shi M
Int J Gynecol Cancer; 2016 Oct; 26(8):1472-9. PubMed ID: 27400321
[TBL] [Abstract][Full Text] [Related]
8. GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON.
Hoskin PJ; Sibtain A; Daley FM; Wilson GD
Br J Cancer; 2003 Oct; 89(7):1290-7. PubMed ID: 14520462
[TBL] [Abstract][Full Text] [Related]
9. Chemoradiotherapy response prediction model by proteomic expressional profiling in patients with locally advanced cervical cancer.
Choi CH; Chung JY; Kang JH; Paik ES; Lee YY; Park W; Byeon SJ; Chung EJ; Kim BG; Hewitt SM; Bae DS
Gynecol Oncol; 2020 May; 157(2):437-443. PubMed ID: 32107047
[TBL] [Abstract][Full Text] [Related]
10. Tumor hypoxia, p53, and prognosis in cervical cancers.
Haensgen G; Krause U; Becker A; Stadler P; Lautenschlaeger C; Wohlrab W; Rath FW; Molls M; Dunst J
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):865-72. PubMed ID: 11429213
[TBL] [Abstract][Full Text] [Related]
11. Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry.
Kim BW; Cho H; Chung JY; Conway C; Ylaya K; Kim JH; Hewitt SM
J Transl Med; 2013 Aug; 11():185. PubMed ID: 23927384
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study.
Liao SY; Darcy KM; Randall LM; Tian C; Monk BJ; Burger RA; Fruehauf JP; Peters WA; Stock RJ; Stanbridge EJ
Gynecol Oncol; 2010 Mar; 116(3):452-8. PubMed ID: 19913895
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor 1 promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression.
Sowa T; Menju T; Chen-Yoshikawa TF; Takahashi K; Nishikawa S; Nakanishi T; Shikuma K; Motoyama H; Hijiya K; Aoyama A; Sato T; Sonobe M; Harada H; Date H
Cancer Med; 2017 Jan; 6(1):288-297. PubMed ID: 28028936
[TBL] [Abstract][Full Text] [Related]
14. Propensity Score Analysis of Radical Hysterectomy Versus Definitive Chemoradiation for FIGO Stage IIB Cervical Cancer.
Tomita N; Mizuno M; Makita C; Kondo S; Mori M; Sakata J; Tsubouchi H; Hirata K; Tachibana H; Kodaira T
Int J Gynecol Cancer; 2018 Oct; 28(8):1576-1583. PubMed ID: 30095702
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for pelvic and distant recurrence in locally advanced cervical cancer.
Queiroz ACM; Fabri V; Mantoan H; Sanches SM; Guimarães APG; Ribeiro ARG; da Nogueira Silveira Lima JP; Chen MJ; Baiocchi G; da Costa AABA
Eur J Obstet Gynecol Reprod Biol; 2019 Apr; 235():6-12. PubMed ID: 30771718
[TBL] [Abstract][Full Text] [Related]
16. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma.
Yokoi E; Mabuchi S; Takahashi R; Matsumoto Y; Kuroda H; Kozasa K; Kimura T
J Gynecol Oncol; 2017 Mar; 28(2):e19. PubMed ID: 28028992
[TBL] [Abstract][Full Text] [Related]
17. The significance of tumoral ERCC1 status in patients with locally advanced cervical cancer treated with chemoradiation therapy: a multicenter clinicopathologic analysis.
Doll CM; Aquino-Parsons C; Pintilie M; Klimowicz AC; Petrillo SK; Milosevic M; Craighead PS; Clarke B; Lees-Miller SP; Fyles AW; Magliocco AM
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):721-7. PubMed ID: 22836058
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging features of tumor and lymph node to predict clinical outcome in node-positive cervical cancer: a retrospective analysis.
Park SH; Hahm MH; Bae BK; Chong GO; Jeong SY; Na S; Jeong S; Kim JC
Radiat Oncol; 2020 Apr; 15(1):86. PubMed ID: 32312283
[TBL] [Abstract][Full Text] [Related]
19. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R
Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
